Effect of Cilnidipine on left ventricular diastolic function during isometric handgrip exercise in patients with essential hypertension
Ma Zhi-yong,Li Li,XueZhen Zhong,Hongwei Tan,Rong Wang,Wei Zhang
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.28.016
2006-01-01
Abstract:AIM: To activate the sympathetic nervous system of patients with essential hypertension by isometric handgrip test, so as to evaluate the effect of Cilnidipine on left ventricular diastolic function. METHODS: Forty outpatients with mild to moderate essential hypertension were randomly selected from the Department of Cardiology, Qilu Hospital, Shandong University between March and October 2004, and all the patients agreed to join the observation. In the self-control trail, the patients were treated with Cilnidipine 5 mg, orally once every day after 2 weeks of placebo, and the follow up was done once two weeks. The dosage was increased to 10 mg, orally once every day for 8 weeks if the diastolic pressure was still > 95 mm Hg (1 mm Hg=0.133 kPa) after 2 weeks of administration. Isometric handgrip tests were carried out at the end of placebo period and 8 weeks of administration, respectively; at the same time, the echocardiography was performed to record the indexes of blood pressure, heart rate, left ventricular systolic and diastolic function including left ventricular ejection fraction and minor axis shortening fraction, mitral valve flow pattern E peak, A peak and E/A ratio under the resting and exercising condition. RESULTS: All the 40 patients were involved in the result analysis with no drop. ①The changes of blood pressure before and after 8 weeks of Cilnidipine treatment at resting and during exercise: The sitting resting systolic pressure and diastolic pressure were all significantly decreased than those before treatment [(129.0±10.0, 87.0±6.4; 148.0±13.1,99.0±3.3) mm Hg, (t=9.68, 13.62, P < 0.01)]; In the isometric handgrip test, the exercise systolic pressure and diastolic pressure were all decreased than those at the end of placebo period [(163.9±18.22, 104.3±9.33; 172.1±17.89, 111.4±11.86) mm Hg, (t=3.07, 3.22, P < 0.01)]. ②The changes of diastolic function before and after 8 weeks of Cilnidipine treatment at rest and during exercise: Compared with the period of the end of placebo, the resting and exercise A velocity after 8 weeks of Cilnidipine significantly decreased (t=6.89, 5.83, P < 0.01), and the resting E/A ratio and exercise E/A ratio were significantly increased (t=-5.89, -5.65, P < 0.01). CONCLUSION: Cilnidipine can decrease the blood pressure not only at rest but also during a stress event, and release the activation of sympathetic nervous system in patients with essential hypertension. Furthermore, it can effectively improve left ventricular diastolic function, not only at rest but also during exercise.